Table I.
Treatment group | Number with ACF/total number rats | Tea exposure protocol | ACF per colon (mean ± SD) | ACF/ACF-bearing animal (mean ± SD) |
---|---|---|---|---|
IQ | 10/14 | none | 1.7 ± 1.73 | 2.40 ±1.58 |
8/15 | continuous | 1.6 ± 1.88 | 3.00 ±1.51 | |
IQ+GT | 3/15 | initiation | 0.2 ± 0.41** | 1.00 ± 0.00* |
15/15 | post-initiation | 4.5 ± 2.72 | 4.47 ± 2.72 | |
5/15 | continuous | 0.7 ±1.39* | 2.20 ± 1.64 | |
IQ+BT | 5/15 | initiation | 0.5 ± 0.92* | 1.60 ± 0.89* |
8/14 | post-initiation | 0.9 ± 0.95* | 1.50 ± 0.76 |
Note. IQ, 2-amino-3-methylimidazo[4,5-f]quinoline; GT, green tea (2% w/v); BT, black tea (2% w/v); P < 0.05* or 0.01** by Students t test versus controls given IQ alone.